AJANTA PHARMA
|
The Current P/E Ratio of AJANTA PHARMA is 32.42.
| Share Price | ₹2,527.6 | Nov 10,2025 |
| Market Cap | ₹31,569.1 Cr | |
| Earnings-TTM | ₹973.7 Cr | TTM-Consolidated Results |
| Price/Earnings | 32.42x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AJANTA PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹31,569.1 Cr] as on Nov 10,2025
(/) Earnings [ ₹973.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 32.42x ]
Thus, for AJANTA PHARMA , the investors are currently willing to pay 32.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AJANTA PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AJANTA PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of AJANTA PHARMA
PE Ratio Performance Analysis for AJANTA PHARMA
- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 25.24x.
- AJANTA PHARMA 's operated at median p/e ratio of 25.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2025 at 35.53x.
- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2022 of 14.45x.
How does AJANTA PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AJANTA PHARMA | 973.67 | 32.42 | 31,569.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 38.72 | 407,287.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 71.49 | 177,657.0 |
| CIPLA LTD | 5,453.86 | 22.42 | 122,276.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.37 | 129,202.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.48 | 100,024.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.23 | 92,301.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 19.16 | 95,295.4 |
| LUPIN LTD | 4,347.53 | 20.88 | 90,774.6 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.42 | 66,969.3 |
| ABBOTT INDIA LTD | 1,508.95 | 41.54 | 62,678.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AJANTA PHARMA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.48x |
| Max industry PE | 71.49x |
| Median industry PE | 32.42x |
| Average industry PE | 36.01x |
You may also like the below Video Courses